DexCom (DXCM): Assessing Valuation After Surge in Lawsuits Over Device Safety and Reliability

DexCom (DXCM) is under the spotlight after several class action lawsuits were filed claiming the company made unauthorized changes to its G6 and G7 glucose monitoring devices. These changes could ...

Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)

Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Québec government for its recent decision to ...

DexCom, Inc. (DXCM) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DXCM Investors of Securities Fraud Class Action Lawsuit

Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the firm directly to acquire more information. CLICK HERE TO SIGN UP FOR THE CASE OR GO ...

Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for Investors - Contact Levi & Korsinsky

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DexCom, Inc. investors who were adversely affected by alleged securities fraud between July 26, 2024 and September 17, 2025. Follow ...
Le Lézard

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

Levi & Korsinsky, LLP notifies investors in DexCom, Inc. ("DexCom, Inc." or the "Company") of a class action securities ...